Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 11526216)

1.

A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection.

Dube PH, Revell PA, Chaplin DD, Lorenz RG, Miller VL.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10880-5. Epub 2001 Aug 28.

2.

Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica.

Bohn E, Heesemann J, Ehlers S, Autenrieth IB.

Infect Immun. 1994 Jul;62(7):3027-32.

3.

Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.

Bohn E, Schmitt E, Bielfeldt C, Noll A, Schulte R, Autenrieth IB.

Infect Immun. 1998 May;66(5):2213-20.

5.

Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.

Di Genaro MS, Cargnelutti DE, Eliçabe JR, Lacoste MG, Valdez S, Gómez N, de Guzmán AM.

Rheumatology (Oxford). 2007 Apr;46(4):590-6. Epub 2006 Oct 13.

6.
7.

Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.

Matteoli G, Fahl E, Warnke P, Müller S, Bonin M, Autenrieth IB, Bohn E.

BMC Microbiol. 2008 Sep 19;8:153. doi: 10.1186/1471-2180-8-153.

9.
10.

IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice.

Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto M, Heesemann J, Autenrieth IB.

J Immunol. 1998 Jan 1;160(1):299-307.

11.

Tumor necrosis factor-alpha expression induced by anti-YopB antibodies coincides with protection against Yersinia enterocolitica infection in mice.

Burdack S, Schmidt A, Knieschies E, Röllinghoff M, Beuscher HU.

Med Microbiol Immunol. 1997 Mar;185(4):223-9.

PMID:
9138294
12.

Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.

Cai K, Zhang Y, Yang B, Chen S.

Vaccine. 2013 Jan 2;31(2):334-40. doi: 10.1016/j.vaccine.2012.11.004. Epub 2012 Nov 12.

PMID:
23153438
13.
14.

Bacterial cytokine antagonists encoded by pathogenic yersiniae.

Beuscher HU, Burdack S, Röllinghoff M.

Behring Inst Mitt. 1997 Feb;(98):240-8.

PMID:
9382746
15.

Comparison of the cytokine immune response to pathogenic Yersinia enterocolitica bioserotype 1B/O:8 and 2/O:9 in susceptible BALB/C and resistant C57BL/6 mice.

Wang X, Gu W, Qiu H, Xia S, Zheng H, Xiao Y, Liang J, Jing H.

Mol Immunol. 2013 Oct;55(3-4):365-71. doi: 10.1016/j.molimm.2013.03.017. Epub 2013 Apr 10.

PMID:
23582306
16.

Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates.

Echeverry A, Saijo S, Schesser K, Adkins B.

Infect Immun. 2010 Aug;78(8):3595-608. doi: 10.1128/IAI.01272-09. Epub 2010 Jun 1.

17.

Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA.

Di Genaro MS, Cargnelutti DE, Castro DO, Eliçabe RJ, Gutiérrez JV, Correa SG, de Guzmán AM.

Scand J Rheumatol. 2007 Jan-Feb;36(1):28-35.

PMID:
17454932
18.

Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.

Heesemann J, Gaede K, Autenrieth IB.

APMIS. 1993 Jun;101(6):417-29. Review.

PMID:
8363822
19.

Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.

Sing A, Tvardovskaia N, Rost D, Kirschning CJ, Wagner H, Heesemann J.

Int J Med Microbiol. 2003 Nov;293(5):341-8.

PMID:
14695062
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk